MONTREAL, 3 de octubre de 2023 /PRNewswire/ — Knight Therapeutics Inc. (TSX:GUD) (“Knight” o “la Empresa”) se complace en anunciar que ha sido colocada en el puesto número 90 en la clasificación del año 2023 de Canada’s Top Growing Companies de Report on Business. El ranking Canada’s Top…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.